Find therapies in clinical trials near you – page 2

Study of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis

Study of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis

Study of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease

Study of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease

Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

Study of Elafibranor for Adults with Primary Biliary Cholangitis

Study of Elafibranor for Adults with Primary Biliary Cholangitis

Study on the Effectiveness of PQ Grass for Children and Teens with Seasonal Allergies from Grass Pollen

Study on the Effectiveness of PQ Grass for Children and Teens with Seasonal Allergies from Grass Pollen

Study on the Long-Term Effects and Safety of Mirikizumab for Patients with Crohn's Disease

Study on the Long-Term Effects and Safety of Mirikizumab for Patients with Crohn's Disease

Study on the Effects of Finerenone in Patients with Heart Failure and Preserved Ejection Fraction Hospitalized for Acute Decompensated Heart Failure

Study on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors

Study on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors

Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

Rinatabart Sesutecan with or without bevacizumab versus standard platinum‑based chemotherapy drug combination in patients with recurrent platinum‑sensitive ovarian cancer

Rinatabart Sesutecan with or without bevacizumab versus standard platinum‑based chemotherapy drug combination in patients with recurrent platinum‑sensitive ovarian cancer

A Phase 3 Study of Engasertib to Evaluate Safety and Effectiveness in Adults with Moderate to Severe Hereditary Hemorrhagic Telangiectasia

A Phase 3 Study of Engasertib to Evaluate Safety and Effectiveness in Adults with Moderate to Severe Hereditary Hemorrhagic Telangiectasia

Efficacy and safety of ABP 938 compared with aflibercept in participants with neovascular age‑related macular degeneration

Efficacy and safety of ABP 938 compared with aflibercept in participants with neovascular age‑related macular degeneration